Treprostinil s.k. is indicated for the treatment of:
- Primary pulmonary arterial hypertension.
- Pulmonary arterial hypertension is associated with connective tissue disorders.
- Pulmonary hypertension is associated with congenital systemic to pulmonary shunts.
Disclaimer:
The images and designs presented on this website are for illustrative purposes only. Actual products may differ from those shown, including variations in color, packaging design, wording, or other visual features. The company assumes no responsibility for any such discrepancies and does not undertake to update the website to reflect changes in the actual product.
